Filing Details
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event.
8k filedNASDAQ:TNYA
Tenaya Therapeutics, Inc. (TNYA) Reports Material Event to SEC
Filing Details Tenaya Therapeutics, Inc. (NASDAQ:TNYA) filed a Form 8-K with the Securities and Exchange Commission on June 29, 2026, disclosing a material event. Market Context…
Market Context
Tenaya Therapeutics, Inc.'s stock currently trades at $0.73 with a market capitalization of $227.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Tenaya Therapeutics, Inc.'s stock.
All SEC filings for Tenaya Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TNYA Stock Page
Frequently Asked Questions
Where can I read TNYA's SEC filings?
Browse all filings on our TNYA SEC filings page.
What types of SEC filings does Tenaya Therapeutics, Inc. file?
Public companies like Tenaya Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.